The novel treatment of the medication represents a exciting development in the management of type 2 diabetes. Different to existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide630045.blog5star.com/42497524/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment